KalVista Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
KalVista Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker KALV.
KalVista Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical firm dedicated to the discovery, development, and commercialization of small molecule protease inhibitors. These inhibitors aim to address diseases with significant unmet medical needs. The company's core therapeutic strategy centers on its pipeline of small molecule plasma kallikrein inhibitors. These are specifically engineered to combat...
Can you invest in KalVista Pharmaceuticals, Inc.?
Yes. KalVista Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker KALV.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for KalVista Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.